Title : Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension.

Pub. Date : 2017 Aug 25

PMID : 28420826






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Efficacy and Safety of an Orally Administered Selective Prostacyclin Receptor Agonist, Selexipag, in Japanese Patients With Pulmonary Arterial Hypertension. selexipag prostaglandin I2 receptor Homo sapiens
2 BACKGROUND: Selexipag is an orally available prostacyclin receptor (IP receptor) agonist with a non-prostanoid structure. selexipag prostaglandin I2 receptor Homo sapiens